Brain TumorsNCT00557375
Brain Tumor Treatment Satisfaction Survey
An observational study of Brain Tumors, run by Methodist Healthcare - Memphis at 1 site in United States.
Trial summary
Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Brain Tumors
- How many people
- 105 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jun 2007to 1 Mar 2009
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Brain tumor patients and their caregivers
Who may be able to join
- Patients who are between 3 months and one year out from treatment for their brain tumor
- Karnofsky Performance Status (KPS) >= 60
- Age 18 years or over, any gender, any race
- "patient caregivers will be individuals who provide the most day-to-day care for their respective brain tumor patients
Who cannot join
- No exclusions
Trial locations and contacts
1 site in 1 country.
United States1 site
Methodist University Hospital
Memphis, Tennessee, 38104
About this study
Official title: Treatment Satisfaction Survey for Brain Tumor Patients and Their Caregivers
Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Caregivers will complete a one-page questionnaire concerning the patient's quality of life and emotional state since receiving treatment.
Read the detailed description
Patients with a recent diagnosis and treatment of a brain tumor (primary or metastatic; N=105, 61% female, 39% male) were identified in the clinics of Semmes-Murphey Neurologic and Spine Institute or the Methodist University Hospital in Memphis, TN. Caregivers were recruited from among relatives and friends who provide the most day-to-day care to the patient. All participants were between 3 months and 1 year from their most recent brain tumor treatment. Participants were given a simple, 5-point based survey to asses treatment-specific satisfaction, patient education, posttreatment quality of life, and pre- and post-treatment emotional impact. Therapeutic modalities surveyed include: surgery, external beam radiotherapy, whole-brain radiotherapy, stereotactic radiosurgery, and chemotherapy.
- Conditions
- Brain Tumors
- Keywords
- Brain Tumors, Survey
- Medical subject headings
- Brain Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| 1 | Brain tumor patients | |
| 2 | Caregivers of brain tumor patients |
What is being measured
The primary outcome is the main question the study is designed to answer.
Overall satisfaction and emotional impact of treatments in patients who have undergone therapy(s)for brain tumors.
Measured: (greater than or equal to 3 months) from first treatment for brain tumor
Secondary outcomes (1)
Observational data about the treatment course and emotional well-being of the brain tumor patient as provided by the caregiver.
Measured: (Greater than or equal to 3 months) from first treatment for brain tumor
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Nov 2007 (estimated)
- Study start1 Jun 2007
- Primary completion1 Mar 2009
- Study completion1 Mar 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Brain TumorsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 105 participants (actual)
Sponsor and investigators
- Lead sponsor
- Methodist Healthcare - Memphis
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Jeffrey M. Sorenson, MD, Principal investigator, Methodist Healthcare - Memphis
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00557375
- Sponsor's protocol ID
- MHIRB 2007-036
- Status last verified
- Apr 2022
- First submitted
- 13 Nov 2007
- Last updated
- 11 Apr 2022
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Apr 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Treatment Satisfaction Survey for Brain Tumor Patients and Their Caregivers
- ClinicalTrials.gov ID
- NCT00557375
- Acronym / sponsor ID
- MHIRB 2007-036
- Conditions
- Brain Tumors
- Keywords
- Brain Tumors, Survey
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 105 participants (actual)
- Lead sponsor
- Methodist Healthcare - MemphisUniversity, hospital or other
- Study start
- 1 Jun 2007 (actual)
- Primary completion
- 1 Mar 2009 (actual)
- Study completion
- 1 Mar 2009 (actual)
- First posted
- 14 Nov 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Caregivers will complete a one-page questionnaire concerning the patient's quality of life and emotional state since receiving treatment.
Detailed description
Patients with a recent diagnosis and treatment of a brain tumor (primary or metastatic; N=105, 61% female, 39% male) were identified in the clinics of Semmes-Murphey Neurologic and Spine Institute or the Methodist University Hospital in Memphis, TN. Caregivers were recruited from among relatives and friends who provide the most day-to-day care to the patient. All participants were between 3 months and 1 year from their most recent brain tumor treatment. Participants were given a simple, 5-point based survey to asses treatment-specific satisfaction, patient education, posttreatment quality of life, and pre- and post-treatment emotional impact. Therapeutic modalities surveyed include: surgery, external beam radiotherapy, whole-brain radiotherapy, stereotactic radiosurgery, and chemotherapy.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| 1 | – | –Brain tumor patients |
| 2 | – | –Caregivers of brain tumor patients |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Brain tumor patients and their caregivers
Key inclusion criteria (4 listed)
- Patients who are between 3 months and one year out from treatment for their brain tumor
- Karnofsky Performance Status (KPS) >= 60
- Age 18 years or over, any gender, any race
- "patient caregivers will be individuals who provide the most day-to-day care for their respective brain tumor patients
Key exclusion criteria (1 listed)
- No exclusions
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Overall satisfaction and emotional impact of treatments in patients who have undergone therapy(s)for brain tumors.
Time frame: (greater than or equal to 3 months) from first treatment for brain tumor
1 secondary outcome
Observational data about the treatment course and emotional well-being of the brain tumor patient as provided by the caregiver.
Time frame: (Greater than or equal to 3 months) from first treatment for brain tumor
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Apr 2022.
Related trials for Brain Tumors
Active, not recruitingPhase 2
Genetic Testing in Guiding Treatment for Patients With Brain Metastases
CDK Gene Mutation, Metastatic Malignant Neoplasm in the Brain
RecruitingPhase 1
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
Adult Glioblastoma, High Grade Glioma
RecruitingPhase 1
ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients
Recurrent Oligodendroglioma, Progressive Oligodendroglioma
Not yet recruitingPhase 1
IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)
High-grade Glioma, Diffuse Intrinsic Pontine Glioma
RecruitingObservational study
Exploration of Whole-Brain Radiotherapy Combined With PD-1 Inhibitors on Brain Injury
Small Cell Lung Cancer ( SCLC ), Brain Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jeffrey M. Sorenson, MD principal investigator
Methodist Healthcare - Memphis
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Brain Tumors, run by Methodist Healthcare - Memphis at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Overall satisfaction and emotional impact of treatments in patients who have undergone therapy(s)for brain tumors. (time frame: (greater than or equal to 3 months) from first treatment for brain tumor). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Apr 2022; AzTrials last refreshed its copy on 31 Oct 2026.